These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15194601)

  • 41. Discontinuation of Long-Term Antipsychotic Drug Use for Behavioral and Psychological Symptoms in Older Adults Aged 65 Years and Older With Dementia.
    Van Leeuwen E; Petrovic M; van Driel ML; De Sutter AI; Stichele RV; Declercq T; Christiaens T
    J Am Med Dir Assoc; 2018 Nov; 19(11):1009-1014. PubMed ID: 30100234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008559. PubMed ID: 28791693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Hussein M; Ahmed U; Rehman FU; Miramontes K; Adams CE
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009412. PubMed ID: 29634083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.
    Bergman H; Rathbone J; Agarwal V; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD000459. PubMed ID: 29409162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia.
    Gareri P; De Fazio P; Manfredi VG; De Sarro G
    J Clin Psychopharmacol; 2014 Feb; 34(1):109-23. PubMed ID: 24158020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of pharmacotherapy for Alzheimer's disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials.
    Seibert M; Mühlbauer V; Holbrook J; Voigt-Radloff S; Brefka S; Dallmeier D; Denkinger M; Schönfeldt-Lecuona C; Klöppel S; von Arnim CAF
    Alzheimers Res Ther; 2021 Jul; 13(1):131. PubMed ID: 34271969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antipsychotic discontinuation in patients with dementia: a systematic review and meta-analysis of published randomized controlled studies.
    Pan YJ; Wu CS; Gau SS; Chan HY; Banerjee S
    Dement Geriatr Cogn Disord; 2014; 37(3-4):125-40. PubMed ID: 24157687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis.
    Tan L; Tan L; Wang HF; Wang J; Tan CC; Tan MS; Meng XF; Wang C; Yu JT
    Alzheimers Res Ther; 2015; 7(1):20. PubMed ID: 25897331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clozapine versus other atypical antipsychotics for schizophrenia.
    Asenjo Lobos C; Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Leucht S
    Cochrane Database Syst Rev; 2010 Nov; (11):CD006633. PubMed ID: 21069690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.
    Katz IR; Jeste DV; Mintzer JE; Clyde C; Napolitano J; Brecher M
    J Clin Psychiatry; 1999 Feb; 60(2):107-15. PubMed ID: 10084637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are atypical antipsychotics safer than typical antipsychotics for treating behavioral and psychological symptoms of dementia?
    Gurevich A; Guller V; Berner YN; Tal S
    J Nutr Health Aging; 2012; 16(6):557-61. PubMed ID: 22659997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms in dementia: a meta-analysis].
    Xue XJ; He RL; Li WX; Xin JW; Ye QY; Chen XC; Pan XD
    Zhonghua Yi Xue Za Zhi; 2018 Jul; 98(25):2030-2036. PubMed ID: 29996606
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).
    Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G
    Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.